{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug delivery", "extracellular vesicles", "inflammatory bowel disease", "medicinal plant", "nanomedicine", "plant exosome-like nanovesicles", "synthetic nanoparticles", "traditional Chinese medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37033644", "DateRevised": {"Year": "2023", "Month": "04", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "23"}], "Language": ["eng"], "ELocationID": ["1158945", "10.3389/fphar.2023.1158945"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Medicinal plant-based drug delivery system for inflammatory bowel disease.", "Pagination": {"StartPage": "1158945", "MedlinePgn": "1158945"}, "Abstract": {"AbstractText": ["Inflammatory bowel disease (IBD) is a chronic recurrent intestinal disease. The incidence rate of IBD is increasing year by year, which seriously endangers human health worldwide. More and more studies have shown that medicinal plants or their main phytochemicals have great potential in the treatment of intestinal diseases. However, the disadvantages of low oral absorption rate, low biological distribution and low systemic bioavailability limit their clinical application to a certain extent. In recent years, the application of nanotechnology has made it possible to treat IBD. Nanoparticles (NPs) drug delivery system has attracted special attention in the treatment of IBD due to its small size, low immunogenicity, surface modification diversity, targeting and other advantages. Synthetic nanoparticles and extracellular vehicles (EVs) can deliver drug components to colon, and play a role in anti-inflammation, regulation of oxidative stress, improvement of intestinal flora, etc. In addition, some medicinal plants can secrete EVs by themselves, and carry biological molecules with therapeutic effects to act on the intestine. Some clinical trials to evaluate the safety, tolerance, toxicity and effectiveness of EVs-loaded drugs in IBD are also progressing steadily. This review introduces that synthetic nanoparticles and medicinal plants derived EVs can play an important role in the treatment of IBD by carrying the effective active phytochemicals of medicinal plants, and discuss the limitations of current research and future research needs, providing a scientific and reliable basis and perspective for further clinical application and promotion."], "CopyrightInformation": "Copyright \u00a9 2023 Li, Wang, Lyu, Shan, Chen, Chen, Chen, Hu, Dou, Zhang, Wang, Zhao and Li."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Li", "ForeName": "Ningcen", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Qingdao Hospital of Traditional Chinese Medicine (Qingdao Hiser Hospital), Qingdao, Shandong, China."}], "LastName": "Wang", "ForeName": "Meijuan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Lyu", "ForeName": "Zhongxi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Qingdao Hospital of Traditional Chinese Medicine (Qingdao Hiser Hospital), Qingdao, Shandong, China."}], "LastName": "Shan", "ForeName": "Kai", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Chen", "ForeName": "Zelin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}, {"Identifier": [], "Affiliation": "Binhai New Area Hospital of TCM, Fourth Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Chen", "ForeName": "Bo", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Chen", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Hu", "ForeName": "Xiyou", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Dou", "ForeName": "Baomin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Zhang", "ForeName": "Jingyu", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Wang", "ForeName": "Lifen", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}, {"Identifier": [], "Affiliation": "School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China."}], "LastName": "Zhao", "ForeName": "Tianyi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Li", "ForeName": "Hongjiao", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer XW declared a shared affiliation with the author HL to the handling editor at the time of review."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Al-Drees A., Khalil M. S. (2016). Histological and immunohistochemical effects of L-arginine and silymarin on TNBS-induced inflammatory bowel disease in rats. Histol. Histopathol. 31 (11), 1259\u20131270. 10.14670/HH-11-757", "ArticleIdList": ["10.14670/HH-11-757", "26979994"]}, {"Citation": "Andujar I., Rios J. L., Giner R. M., Miguel C. J., Recio M. C. (2012). Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c mice. Evid. Based Complement. Altern. Med. 2012271606, 271606. 10.1155/2012/271606", "ArticleIdList": ["10.1155/2012/271606", "PMC3549420", "23346196"]}, {"Citation": "Andujar I., Rios J. L., Giner R. M., Recio M. C. (2013). Shikonin promotes intestinal wound healing in vitro via induction of TGF-beta release in IEC-18 cells. Eur. J. Pharm. Sci. 49 (4), 637\u2013641. 10.1016/j.ejps.2013.05.018", "ArticleIdList": ["10.1016/j.ejps.2013.05.018", "23727294"]}, {"Citation": "Aqil F., Munagala R., Jeyabalan J., Agrawal A. K., Gupta R. (2017). Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. AAPS J. 19 (6), 1691\u20131702. 10.1208/s12248-017-0154-9", "ArticleIdList": ["10.1208/s12248-017-0154-9", "29047044"]}, {"Citation": "Ashikawa K., Majumdar S., Banerjee S., Bharti A. C., Shishodia S., Aggarwal B. B. (2002). Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol. 169 (11), 6490\u20136497. 10.4049/jimmunol.169.11.6490", "ArticleIdList": ["10.4049/jimmunol.169.11.6490", "12444159"]}, {"Citation": "Baliga M. S., Joseph N., Venkataranganna M. V., Saxena A., Ponemone V., Fayad R. (2012). Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: Preclinical and clinical observations. Food Funct. 3 (11), 1109\u20131117. 10.1039/c2fo30097d", "ArticleIdList": ["10.1039/c2fo30097d", "22833299"]}, {"Citation": "Beloqui A., Coco R., Memvanga P. B., Ucakar B., des Rieux A., Preat V. (2014). pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Int. J. Pharm. 473 (1-2), 203\u2013212. 10.1016/j.ijpharm.2014.07.009", "ArticleIdList": ["10.1016/j.ijpharm.2014.07.009", "25014369"]}, {"Citation": "Beloqui A., Memvanga P. B., Coco R., Reimondez-Troitino S., Alhouayek M., Muccioli G. G., et al. (2016). A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Colloids Surf. B Biointerfaces 143, 143327\u2013143335. 10.1016/j.colsurfb.2016.03.038", "ArticleIdList": ["10.1016/j.colsurfb.2016.03.038", "27022873"]}, {"Citation": "Blanco E., Shen H., Ferrari M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33 (9), 941\u2013951. 10.1038/nbt.3330", "ArticleIdList": ["10.1038/nbt.3330", "PMC4978509", "26348965"]}, {"Citation": "Boesch-Saadatmandi C., Loboda A., Wagner A. E., Stachurska A., Jozkowicz A., Dulak J., et al. (2011). Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: Role of miR-155. J. Nutr. Biochem. 22 (3), 293\u2013299. 10.1016/j.jnutbio.2010.02.008", "ArticleIdList": ["10.1016/j.jnutbio.2010.02.008", "20579867"]}, {"Citation": "Dad H. A., Gu T. W., Zhu A. Q., Huang L. Q., Peng L. H. (2021). Plant exosome-like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms. Mol. Ther. 29 (1), 13\u201331. 10.1016/j.ymthe.2020.11.030", "ArticleIdList": ["10.1016/j.ymthe.2020.11.030", "PMC7791080", "33278566"]}, {"Citation": "NIDHI Dadwal A., Hallan S. S., Sharma S., Mishra N. (2017). Development of enteric-coated microspheres of embelin for their beneficial pharmacological potential in ulcerative colitis. Artif. Cells Nanomed Biotechnol. 45 (6), 1\u20139. 10.1080/21691401.2016.1202258", "ArticleIdList": ["10.1080/21691401.2016.1202258", "27388946"]}, {"Citation": "Di Gioia S., Hossain M. N., Conese M. (2020). Biological properties and therapeutic effects of plant-derived nanovesicles. Open Med. (Wars) 15 (1), 1096\u20131122. 10.1515/med-2020-0160", "ArticleIdList": ["10.1515/med-2020-0160", "PMC7718644", "33336066"]}, {"Citation": "Diez-Echave P., Ruiz-Malagon A. J., Molina-Tijeras J. A., Hidalgo-Garcia L., Vezza T., Cenis-Cifuentes L., et al. (2021). Silk fibroin nanoparticles enhance quercetin immunomodulatory properties in DSS-induced mouse colitis. Int. J. Pharm. 606120935, 120935. 10.1016/j.ijpharm.2021.120935", "ArticleIdList": ["10.1016/j.ijpharm.2021.120935", "34310954"]}, {"Citation": "Feng J., Wang Y., Lv Y., Fang S., Ren M., Yao M., et al. (2022). XA pH-responsive and colitis-targeted nanoparticle loaded with shikonin for the oral treatment of inflammatory bowel disease in mice. Mol. Pharm. 19 (11), 4157\u20134170. 10.1021/acs.molpharmaceut.2c00550", "ArticleIdList": ["10.1021/acs.molpharmaceut.2c00550", "36106774"]}, {"Citation": "Feng Z., Jiao L., Wu Z., Xu J., Gu P., Xu S., et al. (2021). A novel nanomedicine ameliorates acute inflammatory bowel disease by regulating macrophages and T-cells. Mol. Pharm. 18 (9), 3484\u20133495. 10.1021/acs.molpharmaceut.1c00415", "ArticleIdList": ["10.1021/acs.molpharmaceut.1c00415", "34310145"]}, {"Citation": "Feng Z., Peng S., Wu Z., Jiao L., Xu S., Wu Y., et al. (2021). Ramulus mori polysaccharide-loaded PLGA nanoparticles and their anti-inflammatory effects in vivo . Int. J. Biol. Macromol. 182, 1822024\u20131822036. 10.1016/j.ijbiomac.2021.05.200", "ArticleIdList": ["10.1016/j.ijbiomac.2021.05.200", "34087293"]}, {"Citation": "Flynn S., Eisenstein S. (2019). Inflammatory bowel disease presentation and diagnosis. Surg. Clin. North Am. 99 (6), 1051\u20131062. 10.1016/j.suc.2019.08.001", "ArticleIdList": ["10.1016/j.suc.2019.08.001", "31676047"]}, {"Citation": "Gandhi H., Rathore C., Dua K., Vihal S., Tambuwala M. M., Negi P. (2020). Efficacy of resveratrol encapsulated microsponges delivered by pectin based matrix tablets in rats with acetic acid-induced ulcerative colitis. Drug Dev. Ind. Pharm. 46 (3), 365\u2013375. 10.1080/03639045.2020.1724127", "ArticleIdList": ["10.1080/03639045.2020.1724127", "32041433"]}, {"Citation": "Gao C., Zhou Y., Chen Z., Li H., Xiao Y., Hao W., et al. (2022). Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Theranostics 12 (12), 5596\u20135614. 10.7150/thno.73650", "ArticleIdList": ["10.7150/thno.73650", "PMC9330521", "35910802"]}, {"Citation": "Gowd V., Kanikajori C., Chaudhary A. A., Rudayni H. A., Rashid S., Khan R. (2022). Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease, 109109101.J. Nutr. Biochem.", "ArticleIdList": ["35777588"]}, {"Citation": "Haag L. M., Siegmund B. (2015). Intestinal microbiota and the innate immune system - a crosstalk in Crohn's disease pathogenesis. Front. Immunol. 6489, 489. 10.3389/fimmu.2015.00489", "ArticleIdList": ["10.3389/fimmu.2015.00489", "PMC4585200", "26441993"]}, {"Citation": "Habtemariam S. (2016). Berberine and inflammatory bowel disease: A concise review. Pharmacol. Res. 113, 592\u2013599. Pt A. 10.1016/j.phrs.2016.09.041", "ArticleIdList": ["10.1016/j.phrs.2016.09.041", "27697643"]}, {"Citation": "Hu M., Palic D. (2020). Micro- and nano-plastics activation of oxidative and inflammatory adverse outcome pathways. Redox Biol. 37101620, 101620. 10.1016/j.redox.2020.101620", "ArticleIdList": ["10.1016/j.redox.2020.101620", "PMC7767742", "32863185"]}, {"Citation": "Iglesias N., Galbis E., Diaz-Blanco M. J., Lucas R., Benito E., De-Paz M. V. (2019). Nanostructured chitosan-based biomaterials for sustained and colon-specific resveratrol release. Int. J. Mol. Sci. 20 (2), 398. 10.3390/ijms20020398", "ArticleIdList": ["10.3390/ijms20020398", "PMC6359380", "30669264"]}, {"Citation": "Jin K., Luo Z., Zhang B., Pang Z. (2018). Biomimetic nanoparticles for inflammation targeting. Acta Pharm. Sin. B 8 (1), 23\u201333. 10.1016/j.apsb.2017.12.002", "ArticleIdList": ["10.1016/j.apsb.2017.12.002", "PMC5985691", "29872620"]}, {"Citation": "Kaplan G. G., Windsor J. W. (2021). The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 18 (1), 56\u201366. 10.1038/s41575-020-00360-x", "ArticleIdList": ["10.1038/s41575-020-00360-x", "PMC7542092", "33033392"]}, {"Citation": "Karamanidou T., Tsouknidas A. (2021). Plant-derived extracellular vesicles as therapeutic nanocarriers. Int. J. Mol. Sci. 23 (1), 191. 10.3390/ijms23010191", "ArticleIdList": ["10.3390/ijms23010191", "PMC8745116", "35008617"]}, {"Citation": "Karthikeyan A., Young K. N., Moniruzzaman M., Beyene A. M., Do K., Kalaiselvi S., et al. (2021). Curcumin and its modified formulations on inflammatory bowel disease (IBD): The story so far and future outlook. Pharmaceutics 13 (4), 484. 10.3390/pharmaceutics13040484", "ArticleIdList": ["10.3390/pharmaceutics13040484", "PMC8065662", "33918207"]}, {"Citation": "Khan N., Mukhtar H. (2018). Tea polyphenols in promotion of human health. Nutrients 11 (1), 39. 10.3390/nu11010039", "ArticleIdList": ["10.3390/nu11010039", "PMC6356332", "30585192"]}, {"Citation": "Khare T., Palakurthi S. S., Shah B. M., Palakurthi S., Khare S. (2020). Natural product-based nanomedicine in treatment of inflammatory bowel disease. Int. J. Mol. Sci. 21 (11), 3956. 10.3390/ijms21113956", "ArticleIdList": ["10.3390/ijms21113956", "PMC7312938", "32486445"]}, {"Citation": "Khater S. I., Lotfy M. M., Alandiyjany M. N., Alqahtani L. S., Zaglool A. W., Althobaiti F., et al. (2022). Therapeutic potential of quercetin loaded nanoparticles: Novel insights in alleviating colitis in an experimental DSS induced colitis model. Biomedicines 10 (7), 1654. 10.3390/biomedicines10071654", "ArticleIdList": ["10.3390/biomedicines10071654", "PMC9313390", "35884960"]}, {"Citation": "Kim H., Kim M., Myoung K., Kim W., Ko J., Kim K. P., et al. (2020). Comparative lipidomic analysis of extracellular vesicles derived from lactobacillus plantarum APsulloc 331261 living in green tea leaves using liquid chromatography-mass spectrometry. Int. J. Mol. Sci. 21 (21), 8076. 10.3390/ijms21218076", "ArticleIdList": ["10.3390/ijms21218076", "PMC7663264", "33138039"]}, {"Citation": "Kumar G. K., Dhamotharan R., Kulkarni N. M., Honnegowda S., Murugesan S. (2011). Embelin ameliorates dextran sodium sulfate-induced colitis in mice. Int. Immunopharmacol. 11 (6), 724\u2013731. 10.1016/j.intimp.2011.01.022", "ArticleIdList": ["10.1016/j.intimp.2011.01.022", "21296695"]}, {"Citation": "Lashgari N. A., Momeni R. N., Khayatan D., Shayan M., Momtaz S., Roufogalis B. D., et al. (2022). Ginger and its constituents: Role in treatment of inflammatory bowel disease. Biofactors 48 (1), 7\u201321. 10.1002/biof.1808", "ArticleIdList": ["10.1002/biof.1808", "34882874"]}, {"Citation": "Li D. F., Yang M. F., Xu H. M., Zhu M. Z., Zhang Y., Tian C. M., et al. (2022). Nanoparticles for oral delivery: Targeted therapy for inflammatory bowel disease. J. Mater Chem. B 10 (31), 5853\u20135872. 10.1039/d2tb01190e", "ArticleIdList": ["10.1039/d2tb01190e", "35876136"]}, {"Citation": "Li Z., Xu X., Wang Y., Kong L., Han C. (2022). Carrier-free nanoplatforms from natural plants for enhanced bioactivity. Egypt: Journal of Advanced Research.", "ArticleIdList": ["PMC10403678", "36208834"]}, {"Citation": "Liu C., Yan X., Zhang Y., Yang M., Ma Y., Zhang Y., et al. (2022). Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J. Nanobiotechnology 20 (1), 206. 10.1186/s12951-022-01421-w", "ArticleIdList": ["10.1186/s12951-022-01421-w", "PMC9052603", "35488343"]}, {"Citation": "Mao Y., Han M., Chen C., Wang X., Han J., Gao Y., et al. (2021). A biomimetic nanocomposite made of a ginger-derived exosome and an inorganic framework for high-performance delivery of oral antibodies. Nanoscale 13 (47), 20157\u201320169. 10.1039/d1nr06015e", "ArticleIdList": ["10.1039/d1nr06015e", "34846415"]}, {"Citation": "Miroliaee A. E., Esmaily H., Vaziri-Bami A., Baeeri M., Shahverdi A. R., Abdollahi M. (2011). Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture. Toxicol. Mech. Methods 21 (3), 200\u2013208. 10.3109/15376516.2010.547887", "ArticleIdList": ["10.3109/15376516.2010.547887", "21247366"]}, {"Citation": "Mohanan V., Nakata T., Desch A. N., Levesque C., Boroughs A., Guzman G., et al. (2018). C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science 359 (6380), 1161\u20131166. 10.1126/science.aan0814", "ArticleIdList": ["10.1126/science.aan0814", "PMC6008784", "29420262"]}, {"Citation": "Mu J., Zhuang X., Wang Q., Jiang H., Deng Z. B., Wang B., et al. (2014). Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol. Nutr. Food Res. 58 (7), 1561\u20131573. 10.1002/mnfr.201300729", "ArticleIdList": ["10.1002/mnfr.201300729", "PMC4851829", "24842810"]}, {"Citation": "Mutalik S., Suthar N. A., Managuli R. S., Shetty P. K., Avadhani K., Kalthur G., et al. (2016). Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin. Int. J. Biol. Macromol. 86, 86709\u201386720. 10.1016/j.ijbiomac.2015.11.092", "ArticleIdList": ["10.1016/j.ijbiomac.2015.11.092", "26851203"]}, {"Citation": "Naserifar M., Hosseinzadeh H., Abnous K., Mohammadi M., Taghdisi S. M., Ramezani M., et al. (2020). Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats. Life Sci. 262, 262118555. 10.1016/j.lfs.2020.118555", "ArticleIdList": ["10.1016/j.lfs.2020.118555", "33035579"]}, {"Citation": "Ng S. C., Shi H. Y., Hamidi N., Underwood F. E., Tang W., Benchimol E. I., et al. (2017). Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390 (10114), 2769\u20132778. 10.1016/S0140-6736(17)32448-0", "ArticleIdList": ["10.1016/S0140-6736(17)32448-0", "29050646"]}, {"Citation": "Nguyen T. T., Trinh N. T., Tran H. N., Tran H. T., Le P. Q., Ngo D. N., et al. (2021). Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease. J. Control Release 331, 331515\u2013331524. 10.1016/j.jconrel.2020.10.042", "ArticleIdList": ["10.1016/j.jconrel.2020.10.042", "33616078"]}, {"Citation": "Nunes S., Danesi F., Del R. D., Silva P. (2018). Resveratrol and inflammatory bowel disease: The evidence so far. Nutr. Res. Rev. 31 (1), 85\u201397. 10.1017/S095442241700021X", "ArticleIdList": ["10.1017/S095442241700021X", "29191255"]}, {"Citation": "Ochsenkuhn T., D'Haens G. (2011). Current misunderstandings in the management of ulcerative colitis. Gut 60 (9), 1294\u20131299. 10.1136/gut.2010.218180", "ArticleIdList": ["10.1136/gut.2010.218180", "21504997"]}, {"Citation": "Ohno M., Nishida A., Sugitani Y., Nishino K., Inatomi O., Sugimoto M., et al. (2017). Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS One 12 (10), e0185999. 10.1371/journal.pone.0185999", "ArticleIdList": ["10.1371/journal.pone.0185999", "PMC5630155", "28985227"]}, {"Citation": "Plaza-Oliver M., Beloqui A., Santander-Ortega M. J., Castro-Vazquez L., Rodriguez-Robledo V., Arroyo-Jimenez M. M., et al. (2020). Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases. Int. J. Pharm. 586, 586119533. 10.1016/j.ijpharm.2020.119533", "ArticleIdList": ["10.1016/j.ijpharm.2020.119533", "32534160"]}, {"Citation": "Pujara N., Wong K. Y., Qu Z., Wang R., Moniruzzaman M., Rewatkar P., et al. (2021). Oral delivery of beta-lactoglobulin-nanosphere-encapsulated resveratrol alleviates inflammation in winnie mice with spontaneous ulcerative colitis. Mol. Pharm. 18 (2), 627\u2013640. 10.1021/acs.molpharmaceut.0c00048", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c00048", "32437160"]}, {"Citation": "Radmanesh F., Razi M., Shalizar-Jalali A. (2021). Curcumin nano-micelle induced testicular toxicity in healthy rats; evidence for oxidative stress and failed homeostatic response by heat shock proteins 70-2a and 90. Biomed. Pharmacother. 142, 142111945. 10.1016/j.biopha.2021.111945", "ArticleIdList": ["10.1016/j.biopha.2021.111945", "34311173"]}, {"Citation": "Rahman S. U., Li Y., Huang Y., Zhu L., Feng S., Wu J., et al. (2018). Treatment of inflammatory bowel disease via green tea polyphenols: Possible application and protective approaches. Inflammopharmacology 26 (2), 319\u2013330. 10.1007/s10787-018-0462-4", "ArticleIdList": ["10.1007/s10787-018-0462-4", "29532213"]}, {"Citation": "Salah N., Dubuquoy L., Carpentier R., Betbeder D. (2022). Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells. Int. J. Pharm. X 4, 4100114. 10.1016/j.ijpx.2022.100114", "ArticleIdList": ["10.1016/j.ijpx.2022.100114", "PMC8919232", "35295898"]}, {"Citation": "Sharma M., Sharma S., Wadhwa J. (2019). Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder. Artif. Cells Nanomed Biotechnol. 47 (1), 45\u201355. 10.1080/21691401.2018.1543191", "ArticleIdList": ["10.1080/21691401.2018.1543191", "30663410"]}, {"Citation": "Shen C., Zhao L., Du X., Tian J., Yuan Y., Jia M., et al. (2021). Smart responsive quercetin-conjugated glycol chitosan prodrug micelles for treatment of inflammatory bowel diseases. Mol. Pharm. 18 (3), 1419\u20131430. 10.1021/acs.molpharmaceut.0c01245", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c01245", "33522827"]}, {"Citation": "Sun D., Zhuang X., Xiang X., Liu Y., Zhang S., Liu C., et al. (2010). A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18 (9), 1606\u20131614. 10.1038/mt.2010.105", "ArticleIdList": ["10.1038/mt.2010.105", "PMC2956928", "20571541"]}, {"Citation": "Sun Y., Li L., Xia Y., Li W., Wang K., Wang L., et al. (2019). The gut microbiota heterogeneity and assembly changes associated with the IBD. Sci. Rep. 9 (1), 440. 10.1038/s41598-018-37143-z", "ArticleIdList": ["10.1038/s41598-018-37143-z", "PMC6345861", "30679676"]}, {"Citation": "Sung J., Yang C., Collins J. F., Merlin D. (2020). Preparation and characterization of ginger lipid-derived nanoparticles for colon-targeted siRNA delivery. Bio Protoc. 10 (14), e3685. 10.21769/bioprotoc.3685", "ArticleIdList": ["10.21769/bioprotoc.3685", "PMC7416531", "32782915"]}, {"Citation": "Sung J., Yang C., Viennois E., Zhang M., Merlin D. (2019). Isolation, purification, and characterization of ginger-derived nanoparticles (GDNPs) from ginger, rhizome of zingiber officinale. Bio Protoc. 9 (19), e3390. 10.21769/BioProtoc.3390", "ArticleIdList": ["10.21769/BioProtoc.3390", "PMC6857645", "31737748"]}, {"Citation": "Tambuwala M. M., Khan M. N., Thompson P., Mccarron P. A. (2019). Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis. Drug Deliv. Transl. Res. 9 (1), 14\u201324. 10.1007/s13346-018-00597-9", "ArticleIdList": ["10.1007/s13346-018-00597-9", "PMC6328632", "30430451"]}, {"Citation": "van Niel G., D'Angelo G., Raposo G. (2018). Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell. Biol. 19 (4), 213\u2013228. 10.1038/nrm.2017.125", "ArticleIdList": ["10.1038/nrm.2017.125", "29339798"]}, {"Citation": "Varshosaz J., Minaiyan M., Khaleghi N. (2015). Eudragit nanoparticles loaded with silybin: A detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation. J. Microencapsul. 32 (3), 211\u2013223. 10.3109/02652048.2014.995728", "ArticleIdList": ["10.3109/02652048.2014.995728", "25561026"]}, {"Citation": "Verstockt B., Ferrante M., Vermeire S., Van Assche G. (2018). New treatment options for inflammatory bowel diseases. J. Gastroenterol. 53 (5), 585\u2013590. 10.1007/s00535-018-1449-z", "ArticleIdList": ["10.1007/s00535-018-1449-z", "PMC5910475", "29556726"]}, {"Citation": "Wang C., Guo Z., Liang J., Li N., Song R., Luo L., et al. (2022). An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy. Front. Bioeng. Biotechnol. 10, 101025155. 10.3389/fbioe.2022.1025155", "ArticleIdList": ["10.3389/fbioe.2022.1025155", "PMC9684466", "36440435"]}, {"Citation": "Witwer K. W., Wolfram J. (2021). Extracellular vesicles versus synthetic nanoparticles for drug delivery. Nat. Rev. Mater 6 (2), 103\u2013106. 10.1038/s41578-020-00277-6", "ArticleIdList": ["10.1038/s41578-020-00277-6", "PMC9481198", "36117545"]}, {"Citation": "Xu C., Chen S., Chen C., Ming Y., Du J., Mu J., et al. (2022). Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy. Int. J. Pharm., 623121884.", "ArticleIdList": ["35661797"]}, {"Citation": "Yang C., Merlin D. (2019). Nanoparticle-mediated drug delivery systems for the treatment of IBD: Current perspectives. Int. J. Nanomedicine 14, 148875\u2013148889. 10.2147/IJN.S210315", "ArticleIdList": ["10.2147/IJN.S210315", "PMC6859086", "32009785"]}, {"Citation": "Yin L., Yan L., Yu Q., Wang J., Liu C., Wang L., et al. (2022). Characterization of the MicroRNA profile of ginger exosome-like nanoparticles and their anti-inflammatory effects in intestinal caco-2 cells. J. Agric. Food Chem. 70 (15), 4725\u20134734. 10.1021/acs.jafc.1c07306", "ArticleIdList": ["10.1021/acs.jafc.1c07306", "35261246"]}, {"Citation": "Yu W., Chen H., Xiang Z., He N. (2019). Preparation of polysaccharides from ramulus mori, and their antioxidant, anti-inflammatory and antibacterial activities. Molecules 24 (5), 856. 10.3390/molecules24050856", "ArticleIdList": ["10.3390/molecules24050856", "PMC6429365", "30823408"]}, {"Citation": "Yum S., Jeong S., Lee S., Nam J., Kim W., Yoo J. W., et al. (2015). Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: Potential molecular mechanisms for therapeutic enhancement. Drug Des. Devel Ther. 9, 94247\u201394258. 10.2147/DDDT.S88670", "ArticleIdList": ["10.2147/DDDT.S88670", "PMC4532174", "26273188"]}, {"Citation": "Zhang M., Collins J. F., Merlin D. (2016). Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases? Nanomedicine (Lond) 11 (23), 3035\u20133037. 10.2217/nnm-2016-0353", "ArticleIdList": ["10.2217/nnm-2016-0353", "PMC5561796", "27813445"]}, {"Citation": "Zhang M., Viennois E., Prasad M., Zhang Y., Wang L., Zhang Z., et al. (2016). Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Netherlands: Biomaterials, 101321\u2013101340.", "ArticleIdList": ["PMC4921206", "27318094"]}, {"Citation": "Zhang M., Wang X., Han M. K., Collins J. F., Merlin D. (2017). Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine (Lond) 12 (16), 1927\u20131943. 10.2217/nnm-2017-0196", "ArticleIdList": ["10.2217/nnm-2017-0196", "PMC5827822", "28665164"]}, {"Citation": "Zhang M., Xu C., Liu D., Han M. K., Wang L., Merlin D. (2018). Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. J. Crohns Colitis 12 (2), 217\u2013229. 10.1093/ecco-jcc/jjx115", "ArticleIdList": ["10.1093/ecco-jcc/jjx115", "PMC5881712", "28961808"]}, {"Citation": "Zhang S., Langer R., Traverso G. (2017). Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease. England: Nano Today, 1682\u20131696.", "ArticleIdList": ["PMC6557461", "31186671"]}, {"Citation": "Zhao L., Du X., Tian J., Kang X., Li Y., Dai W., et al. (2021). Berberine-loaded carboxylmethyl chitosan nanoparticles ameliorate DSS-induced colitis and remodel gut microbiota in mice. Front. Pharmacol. 12, 12644387. 10.3389/fphar.2021.644387", "ArticleIdList": ["10.3389/fphar.2021.644387", "PMC8093821", "33959013"]}, {"Citation": "Zu M., Ma Y., Cannup B., Xie D., Jung Y., Zhang J., et al. (2021). Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv. Drug Deliv. Rev. 176113887, 113887. 10.1016/j.addr.2021.113887", "ArticleIdList": ["10.1016/j.addr.2021.113887", "34314785"]}, {"Citation": "Zu M., Xie D., Canup B., Chen N., Wang Y., Sun R., et al. (2021). 'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases. Netherlands: Biomaterials, 279121178.", "ArticleIdList": ["34656857"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "4"}, {"Year": "2023", "Month": "3", "Day": "14"}, {"Year": "2023", "Month": "4", "Day": "11", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "4", "Day": "10", "Hour": "3", "Minute": "55"}, {"Year": "2023", "Month": "4", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["37033644", "PMC10076537", "10.3389/fphar.2023.1158945", "1158945"]}}], "PubmedBookArticle": []}